| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105474 Heterocyclic derivatives as hdac inhibitors |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | CA2777749A1 Therapeutic peptides |
| 05/05/2011 | CA2777671A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis |
| 05/04/2011 | EP2316830A2 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors |
| 05/04/2011 | EP2316820A1 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them |
| 05/04/2011 | EP2316457A1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2315746A1 Urea derivatives as antibacterial agents |
| 05/04/2011 | EP2315740A1 Fatty acid acetylated salicylates and their uses |
| 05/04/2011 | EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/04/2011 | CN102046629A Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound |
| 05/04/2011 | CN102046612A Processes for the synthesis of levocetirizine and intermediates for use therein |
| 05/04/2011 | CN102046599A Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions |
| 05/04/2011 | CN102046598A Novel donor-acceptor fluorene scaffolds : a process and uses thereof |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/04/2011 | CN102040567A Method for synthesizing 1-(2-(1-piperidyl) phenyl)-3-methyl butyl amine |
| 05/04/2011 | CN102040559A Gemini dication based acid ionic liquid and preparation method thereof |
| 05/04/2011 | CN102040552A 1, 2-di(cyclic group)substituted benzene derivative |
| 05/04/2011 | CN102040545A Acidic room-temperature ionic liquid using acidic functional tetraalkylguanidine as cations and preparation method thereof |
| 05/04/2011 | CN101481363B Method for preparing repaglinide |
| 05/04/2011 | CN101215274B Technique for preparing N-substituted morpholines organic compounds |
| 05/04/2011 | CN101104608B Solanesol derivative, preparation and application thereof |
| 05/03/2011 | US7935703 Piperazines and piperidines as Mglur5 potentiators |
| 05/03/2011 | US7935685 Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment |
| 05/03/2011 | CA2576067C Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 04/28/2011 | WO2011048004A1 Inhibitors of the microsomal prostaglandin e2 synthase-1 |
| 04/28/2011 | WO2010070371A8 Process for the preparation of piperazine derivatives |
| 04/28/2011 | WO2010070370A8 Process for the preparation of piperazine compounds and hydrochloride salts thereof |
| 04/28/2011 | WO2010070369A8 Piperazine salt and a process for the preparation thereof |
| 04/28/2011 | US20110098485 Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions |
| 04/28/2011 | US20110098392 Compounds having a guanidine structure and use of same as organopolysiloxane polycondensation catalysts |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/27/2011 | EP2313384A1 Phenyl-alkyl piperazines having a modulating activity of tnf |
| 04/27/2011 | EP1670740B1 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 04/27/2011 | CN102036966A Difluorinated tripeptides as HCV serine protease inhibitors |
| 04/27/2011 | CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors |
| 04/27/2011 | CN102030723A Preparation method of trihexyphenidyl hydrochloride |
| 04/27/2011 | CN102030722A Process for the preparation of 4- (3'-chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 04/27/2011 | CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof |
| 04/27/2011 | CN101671317B Preparation method of Naftopidil |
| 04/27/2011 | CN101555235B Manufacture process of piperazine ferulate |
| 04/27/2011 | CN101417988B Biguanide piperazines dipeptidyl peptidase IV inhibitor |
| 04/27/2011 | CN101220008B Synthesis of compound ABT-263 |
| 04/26/2011 | US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 04/26/2011 | US7932269 Sulfonamides as orexin antagonists |
| 04/26/2011 | US7932255 Controlling cell proliferation |
| 04/26/2011 | US7932242 Anticancer agents; radiation and chemical resistance |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/21/2011 | US20110092751 Process for the Preparation of Delmopinol and Derivatives Thereof |
| 04/21/2011 | CA2777565A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
| 04/20/2011 | EP2311799A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311798A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311797A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311796A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310368A1 Small molecule leptin receptor modulators |
| 04/20/2011 | EP2310364A1 Heterocyclic derivatives as hdac inhibitors |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | CN1730475B Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/20/2011 | CN102026986A Hexafluoroisopropanol derivatives |
| 04/20/2011 | CN102026976A Morpholine derivates as antiobesity agents |
| 04/20/2011 | CN102020728A Composite multi-functional-group photoinitiator |
| 04/20/2011 | CN101659644B Method for synthesizing 2-methyl-1-[4-(methylthio)phenyl]-2-(4-morpholinyl)-1-propanon |
| 04/20/2011 | CN101538252B Novel preparation method and intermediate for aripiprazole |
| 04/20/2011 | CN101492430B Method for preparing high-purity cetirizine hydrochloride |
| 04/20/2011 | CN101010312B Quaternary salt CCR2 antagonists |
| 04/19/2011 | US7928239 Anticarcinogenic agents |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011042916A1 A process for the preparation of 2-(2-aminoethoxy) ethanol (2aee) and morpholine with 2aee: morpholine >3 |
| 04/14/2011 | WO2011016016A9 Processes for the preparation of vardenafil |
| 04/14/2011 | US20110087025 Method for producing 3-amidinophenylalanine derivatives |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086311 Base generator, photosensitive resin composition, pattern forming material comprising the photosensitive resin composition, and pattern forming method and article using the photosensitive resin composition |
| 04/13/2011 | EP2308832A1 9-Substituted minocycline compounds |
| 04/13/2011 | EP2308828A2 CaSR antagonist |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2308479A2 Compounds and compositions for delivering active agents |
| 04/13/2011 | EP2307393A1 A process for the preparation of the apoptosis promoter abt-263 |
| 04/13/2011 | EP2307392A2 Processes for the synthesis of levocetirizine and intermediates for use therein |
| 04/13/2011 | EP2307023A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
| 04/13/2011 | EP2307017A1 Compounds which can be used for the treatment of cancers |
| 04/13/2011 | CN102015668A Piperazine derivatives and their use as leptin receptor modulators |
| 04/13/2011 | CN102015666A Reactive ionic liquids |
| 04/13/2011 | CN102015653A Method for the production of halogen-substituted 2-(aminomethylidene)-3- oxobutyric acid esters |
| 04/13/2011 | CN102015652A Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 04/13/2011 | CN102015633A Ketoxime ester compound and use thereof |
| 04/13/2011 | CN102015607A 1,4-naphthoquinone derivatives and therapeutic use thereof |
| 04/13/2011 | CN102015606A IRE-1a inhibitors |
| 04/13/2011 | CN102010386A Method for preparing trimetazidine hydrochloride |